※ PTMD 2.0 database Online Browse Options

Browse result for Progressive supranuclear palsy

※ introduction

    Progressive supranuclear palsy (PSP) is a late-onset neurodegenerative disease involving the gradual deterioration and death of specific volumes of the brain. The condition leads to symptoms including loss of balance, slowing of movement, difficulty moving the eyes, and cognitive impairment. PSP may be mistaken for other types of neurodegeneration such as Parkinson's disease, frontotemporal dementia and Alzheimer's disease. The cause of the condition is uncertain, but involves the accumulation of tau protein within the brain. Medications such as levodopa and amantadine may be useful in some cases. PSP affects about six people per 100,000. The first symptoms typically occur at 60¨C70 years of age. Males are slightly more likely to be affected than females. No association has been found between PSP and any particular race, location, or occupation.

Reference
Wiki: Progressive supranuclear palsy



PTMD IDUniProt AccessionEntrez IDGene NameProtein NameOrganism
PTMD00338P106364137
MAPT
Microtubule-associated protein tau
Homo sapiens
PTMD00857Q151725525
PPP2R5A
Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform
Homo sapiens
PTMD01230P071017054
TH
Tyrosine 3-monooxygenase
Homo sapiens